Glaxo to Acquire Human Genome Sciences (HGSI) for $14 a Share
British pharmaceutical giant GlaxoSmithKline (GSK) is expected to announce an agreement to acquire Rockville, Maryland – based Human Genome Sciences Inc. (HGSI) for about $2.8 billion, or $14 a share, sweetening the offer from its previous $13 per share bid, Reuters reported, citing two people familiar with the situation. The proposed cash purchase, which would give Glaxo [...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here